Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Inflammatory Diseases
  4. Articles

  5. Association of quantitative C-reactive protein with acute myocardial infarction
  6. Scopus by Title (Ref)

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. A decision support model for the necessity of cardio-angiography, a result of generalized additive and logistic regression model

- Rezaeisharif F. , et al.

2. Serum levels of β2-Microglobulin and high sensitive C-reactive protein in ST-elevated and non. ST-elevated myocardial infarction

- Shojaei M. , et al.

3. Comparison of serum level of heat shock protein 27 (HSP 27) and the amount of DNA damage in acute myocardial infarction patients

- Abharzanjani F. , et al.

4. High-sensitive C-reactive protein in patients with acute coronary syndrome in statin therapy and its impact on prognosis

- Qavam S. , et al.

HomeInstructions

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.